Letybo
Letybo (prabotulinumtoxinA) is a next-generation botulinum toxin type A approved by Health Canada, distinct from Botox in its molecular structure and diffusion characteristics. For patients and practitioners who want a neuromodulator with precise, predictable localization, particularly in anatomically demanding areas, Letybo offers a compelling clinical choice administered at WMA by Dr. Kennea, one of seven Allergan Faculty injectors in North America.
What distinguishes Letybo
All botulinum toxin products work through the same mechanism: blocking the neuromuscular junction to temporarily reduce muscle activity. The differences lie in the molecule. Letybo's formulation produces more localized diffusion than some conventional neuromodulators, meaning the effect stays close to the injection point with less spread to adjacent structures.
For technically demanding areas where precise localization is clinically important (the perioral region, delicate brow shaping, lower face work) this property has real value. Onset typically occurs within two to three days, faster than many alternatives, so patients see their result earlier and can make an assessment sooner.
The natural movement profile of Letybo (reduced but preserved) aligns with the outcome WMA pursues for every neuromodulator patient. The goal is a face that is fully expressive and looks like itself. Letybo's characteristics support that goal, particularly in patients with specific anatomical concerns around spread.
Is Letybo right for you?
Letybo is appropriate for most patients seeking neuromodulator treatment. It is particularly discussed with patients who have experienced results from previous treatments that spread slightly beyond the intended area, creating brow heaviness, altered smile dynamics, or unintended effects in adjacent muscle groups.
The decision between neuromodulators is a clinical conversation about anatomy, goals, and treatment history. Dr. Kennea uses whichever product best serves the specific patient and the specific area being treated. That decision happens at consultation and is explained clearly before any treatment begins.
Patients who are pregnant or breastfeeding are not treated. Certain neuromuscular conditions and active skin infections in the treatment area are contraindications reviewed at consultation.
Treatment experience:
The injection procedure is identical to other neuromodulators: fine-gauge needle, 20 to 30 minutes for a full-face treatment, minimal discomfort. Initial effects appear within two to three days, with the full result visible by day ten to fourteen.
Standard aftercare applies: avoid lying flat for four hours, skip intense exercise for 24 hours, and hold facial treatments for 48 hours. Patients who want to minimize bruising are advised to avoid blood thinners and alcohol in the days before their appointment.
Precision placement. Natural expression preserved.
The WMA approach to every neuromodulator treatment is the same regardless of product: preserve natural expression, achieve meaningful reduction, and produce a result that reads as refreshed rather than treated. Letybo's localization profile is a tool that supports that outcome in specific anatomical contexts.
1
Health Canada approved. Rigorously studied and regulated.2
More localized diffusion profile for precision placement in demanding areas3
Faster onset. Results typically visible within 2 to 3 days.
Results
Letybo produces results consistent with premium neuromodulators: meaningful softening of dynamic lines with preserved natural movement. The quality of outcome is comparable to other options in most areas; the clinical distinction is in the degree of placement control, which matters most in technically demanding treatment areas.
Most patients are simply pleased with their result and would not independently identify the specific product used. The goal is always a face that looks exactly like the patient's: rested, refreshed, and entirely their own.
Frequently Asked Questions
Neuromodulator treatments do not require recovery. Treatments are quick and you can return to all regular activities immediately.
Anti-Wrinkle Injection treatments are quick and relatively comfortable. At most, you may experience a small pinprick sensation.
Neuromodulator treatment results manifest over a period of 3-14 days and last an average of 3-6 months depending on the treated area and how quickly an individual’s body metabolizes the treatment.
Your Trusted Providers
At Whistler Medical Aesthetics, every treatment is physician-directed. Dr. Sarah Kennea and the WMA team bring a standard of care that reflects both deep clinical expertise and the precision standard you expect from Canada's premier mountain destination.
Dr. Tara Lynn Teshima
Plastic & Reconstructive Surgeon
Dr. Sarah Kennea
Medical Director
Dr. Natalie Waller ND
Doctor
Krista Stephens
Lead Consultant
